Padhu Srini brings two decades of research experience and five years of commercial experience across molecular biology and genomics. In his commercial career, he held roles at QIAGEN and Thermo Fisher Scientific, supporting customers across the academic, biotech, and pharmaceutical industries in California and Hawaii. Earlier, he built his scientific foundation through research roles, including 10 years at the University of California, Irvine School of Medicine, where he worked across genomics, transcriptomics, metagenomics, and epigenetics.
Padhu holds a PhD in Biotechnology and has authored numerous peer-reviewed publications.